Holen Sie sich die Stockscreener-App
1.16
2.65%
0.03
Schlusskurs vom Vortag:
$1.13
Offen:
$1.12
24-Stunden-Volumen:
301.58K
Relative Volume:
0.69
Marktkapitalisierung:
$25.78M
Einnahmen:
$411.00K
Nettoeinkommen (Verlust:
$-4.85M
KGV:
-2.6364
EPS:
-0.44
Netto-Cashflow:
$-4.88M
1W Leistung:
+4.50%
1M Leistung:
+4.50%
6M Leistung:
+10.48%
1J Leistung:
-53.23%
1-Tages-Spanne:
$1.1156
$1.20
1-Wochen-Bereich:
$1.05
$1.20
52-Wochen-Spanne:
$0.7749
$2.5254
Lexaria Bioscience Corp Stock (LEXX) Company Profile
Firmenname
Lexaria Bioscience Corp
Sektor
Branche
Telefon
250-765-6424
Adresse
100 - 740 MCCURDY ROAD, KELOWNA
Vergleichen Sie LEXX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LEXX
Lexaria Bioscience Corp
|
1.16 | 25.12M | 411.00K | -4.85M | -4.88M | -0.44 |
|
VRTX
Vertex Pharmaceuticals Inc
|
444.64 | 110.88B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
726.21 | 72.79B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
890.11 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
404.46 | 54.85B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
189.85 | 41.41B | 447.02M | -1.18B | -906.14M | -6.1812 |
Lexaria Bioscience Corp Aktie (LEXX) Neueste Nachrichten
Lexaria Bioscience (NASDAQ:LEXX) Downgraded by Wall Street Zen to “Sell” - Defense World
How Lexaria Bioscience Corp. Equity Warrant stock performs in high volatility markets2025 Support & Resistance & Intraday High Probability Setup Alerts - Newser
How Lexaria Bioscience Corp. Equity Warrant stock compares to growth peersJuly 2025 Setups & Verified Technical Signals - Newser
Is Lexaria Bioscience Corp. stock a safe haven assetTake Profit & Risk Adjusted Buy and Sell Alerts - Newser
Lexaria Bioscience (LEXX) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Lexaria Bioscience Corp. (NASDAQ:LEXX): Are Analysts Optimistic? - Yahoo Finance
Lexaria Bioscience (NASDAQ:LEXX) Stock Rating Upgraded by Wall Street Zen - Defense World
Lexaria Bioscience Corp. SEC 10-K Report - TradingView
Lexaria Bioscience : Annual Report for Fiscal Year Ending 08-31, 2025 (Form 10-K) - marketscreener.com
Material Transfer Agreement Between Pharmaceutical Company and Lexaria is Extended - Investing News Network
Lexaria Bioscience Corp. Reports Earnings Results for the Full Year Ended August 31, 2025 - marketscreener.com
Lexaria Bioscience Corp Stock Analysis and ForecastVolatility Index Analysis & Unlock Long-Term Capital Growth Ideas - earlytimes.in
Lexaria Bioscience Corp. Auditor Raises 'Going Concern' Doubt - marketscreener.com
NexMetals Mining (NASDAQ:NEXM) vs. Lexaria Bioscience (OTCMKTS:LXRP) Financial Survey - Defense World
S&P 500, NASDAQ and Dow rise as Wall Street ends volatile week on higher side: M-tron Industries gains nea - The Economic Times
Lexaria Bioscience Corp. (LEXX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
What catalysts could drive Lexaria Bioscience Corp. stock higher2025 Momentum Check & Weekly Chart Analysis and Guides - newser.com
Will Lexaria Bioscience Corp. stock gain from lower inflationQuarterly Earnings Report & Fast Exit/Entry Strategy Plans - newser.com
Will Lexaria Bioscience Corp. Equity Warrant stock deliver long term returns2025 Market Trends & Verified Trade Idea Suggestions - newser.com
Key metrics from Lexaria Bioscience Corp.’s quarterly dataPortfolio Return Summary & Precise Entry and Exit Recommendations - newser.com
Can Lexaria Bioscience Corp. Equity Warrant stock sustain institutional interestMarket Movement Recap & AI Based Buy and Sell Signals - newser.com
Does Lexaria Bioscience Corp. stock trade at a discount to peers2025 AllTime Highs & Free Technical Confirmation Trade Alerts - newser.com
Is Lexaria Bioscience Corp. stock a top momentum playWeekly Trend Recap & Weekly High Potential Alerts - newser.com
Will Lexaria Bioscience Corp. stock deliver consistent dividendsMarket Performance Recap & Expert Verified Movement Alerts - newser.com
Has Lexaria Bioscience Corp. found a price floorJuly 2025 Gainers & Technical Entry and Exit Tips - newser.com
How strong is Lexaria Bioscience Corp. Equity Warrant stock balance sheetJuly 2025 Market Mood & Weekly Breakout Stock Alerts - newser.com
Will Lexaria Bioscience Corp. stock maintain momentum in 2025Trade Analysis Report & Short-Term Trading Opportunity Alerts - newser.com
How to escape a deep drawdown in Lexaria Bioscience Corp. Equity WarrantMarket Risk Analysis & Reliable Price Action Trade Plans - newser.com
How to manage a losing position in Lexaria Bioscience Corp. Equity WarrantSell Signal & Daily Growth Stock Investment Tips - newser.com
How institutional buying supports Lexaria Bioscience Corp. stockAnalyst Upgrade & Accurate Intraday Trade Tips - newser.com
Is Lexaria Bioscience Corp. Equity Warrant stock attractive for passive investors - newser.com
What makes Lexaria Bioscience Corp. Equity Warrant stock attractive to growth fundsBull Run & Risk Managed Trade Strategies - newser.com
Analyzing Lexaria Bioscience Corp. Equity Warrant with risk reward ratio chartsWeekly Risk Report & AI Powered Buy and Sell Recommendations - newser.com
How Lexaria Bioscience Corp. stock performs in rising dollar environment2025 Risk Factors & Consistent Profit Trading Strategies - newser.com
Chart overlay techniques for tracking Lexaria Bioscience Corp.Gap Up & Stepwise Entry and Exit Trade Signals - newser.com
Understanding Lexaria Bioscience Corp. Equity Warrant’s price movement2025 Top Decliners & Safe Capital Growth Trade Ideas - newser.com
Finanzdaten der Lexaria Bioscience Corp-Aktie (LEXX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.45%
0.12%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):